GAS RELIEF- simethicone capsule, liquid filled 
Spirit Pharmaceuticals LLC

----------

Gas Relief

Drug Facts

Active Ingredient (in each tablet)

Simethicone 125 mg

Purpose

Antigas

Uses

for the relief of • pressure, bloating, and fullness commonly referred to as gas

Warnings

Keep out of reach of children

Directions

• adults: swallow with water 1 or 2 softgels as needed after meals and at bedtime • do not exceed 4 softgels in 24 hours except under the advice and supervision of a physician

Other Information

• store at controlled room temperature 20-25°C (68-77°F)
• protect from light, heat, and moisture

Inactive ingredients

FD&C Blue No. 1, FD&C Yellow No. 10, gelatin, glycerin, peppermint oil, purified water, sorbitol sorbitan, titanium dioxide

Questions or comments?

1-888-333-9792

Distributed by:

Cabinet Health P.B.C.

Principal Display Panel

Simethicone 125 mg Jar

GAS RELIEF 
simethicone capsule, liquid filled
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68210-4222
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE125 mg
Inactive Ingredients
Ingredient NameStrength
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
GELATIN (UNII: 2G86QN327L)  
GLYCERIN (UNII: PDC6A3C0OX)  
PEPPERMINT OIL (UNII: AV092KU4JH)  
WATER (UNII: 059QF0KO0R)  
SORBITAN (UNII: 6O92ICV9RU)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorgreenScoreno score
ShapeCAPSULESize8mm
FlavorImprint Code 152
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68210-4222-882 in 1 JAR; Type 0: Not a Combination Product11/14/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00211/14/2022
Labeler - Spirit Pharmaceuticals LLC (179621011)

Revised: 12/2023
Document Id: 0bdef7a9-921e-8119-e063-6394a90aa386
Set id: 7b055389-c038-400d-8c74-ad8fde701fb3
Version: 3
Effective Time: 20231206
 
Spirit Pharmaceuticals LLC